CanSino Biologics details share capital movements in October

CanSino Biologics Inc. reported its monthly movements in securities for October 2025, showing changes in both H shares and A shares. The total authorized/registered share capital at the end of the month stood at RMB 247,449,899.

For H shares, the authorized/registered share capital remained stable at RMB 132,670,900, with 132,670,900 shares outstanding. A new 2025 Core Management H Share Option Scheme, adopted on October 23, 2025, saw the grant of 860,000 share options.

Regarding A shares, the authorized/registered share capital was RMB 114,778,999, with 114,372,901 issued shares (excluding treasury shares) and 406,098 treasury shares. A 2025 Restricted A Share Incentive Scheme, adopted on October 23, 2025, resulted in the grant of 2,054,600 restricted shares on October 27, 2025, at a price of RMB 41.20 per share. The company noted no repurchase of A shares occurred during October 2025.